Citation Impact
Citing Papers
Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma
2014
d-Galactose-induced accelerated aging model: an overview
2019 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
IL-1 Family Members in Cancer; Two Sides to Every Story
2019
Mechanisms of HBV-induced hepatocellular carcinoma
2016
A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration
2016 StandoutNobel
MicroRNAs Associated With HBV Infection And HBV-related HCC
2014
Hepatocellular Carcinoma
2019 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Hepatitis B Virus X Protein-Induced Aberrant Epigenetic Modifications Contributing to Human Hepatocellular Carcinoma Pathogenesis
2013
Polydatin attenuatesd -galactose-induced liver and brain damage through its anti-oxidative, anti-inflammatory and anti-apoptotic effects in mice
2016
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Management of people with early- or very early-stage hepatocellular carcinoma
2017
External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database
2017
Management of hepatocellular carcinoma: an overview of major findings from meta-analyses
2016
Works of Zhongjun Wu being referenced
miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A
2012
Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo
2016
Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma
2013
A Systematic Review of Sorafenib in Child-Pugh A Patients With Unresectable Hepatocellular Carcinoma
2013
IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling
2016
A systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm
2013